Caption Management’s Roivant Sciences ROIV Stock Holding History

Caption Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	+305,000	New	+$9.01M	0.05%	380
2026 Q1	–	Sell	-609,200	Closed	-$13.2M	–	1995
2025 Q4	$13.2M	Sell	609,200 -87,800	-13%	-$1.73M	0.09%	257
2025 Q3	$10.5M	Sell	697,000 -1,303,000	-65%	-$16.1M	0.08%	267
2025 Q2	$22.5M	Buy	+2,000,000	New	+$21.7M	0.25%	79
2024 Q1	–	Sell	-149,900	Closed	-$1.68M	–	1619
2023 Q4	$1.68M	Sell	149,900 -169,400	-53%	-$1.65M	0.02%	662
2023 Q3	$3.73M	Buy	+319,300	New	+$3.61M	0.06%	399

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Caption Management's ROIV Position: Q2 2026 in Review

Caption Management reduced its Roivant Sciences (ROIV) stake by 50% in Q2 2026, selling an estimated $3.24M and leaving 110,000 shares worth $3.89M. The position accounts for 0.02% of the portfolio, ranked #661.

Caption Management first reported a position in ROIV in Q3 2023 and has held it in 9 quarters since. The position peaked at $6.09M in Q1 2026. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Caption Management held 110,000 shares of Roivant Sciences worth $3.89M as of Q2 2026.
Caption Management sold 109,800 Roivant Sciences shares in Q2 2026, an estimated $3.24M.
Roivant Sciences made up 0.02% of Caption Management's portfolio in Q2 2026, its #661 holding.
Caption Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 9 quarters since.
Caption Management's Roivant Sciences position peaked at $6.09M in Q1 2026.
499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.